IN8BIO, INC. Deferred Tax Assets, Operating Loss Carryforwards
IN8BIO, INC. (INAB) had Deferred Tax Assets, Operating Loss Carryforwards of $2.70 million as of 2023-12-31, per its 10-K filed 2024-03-14.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2024-03-14
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $2.70M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2023-12-31 | $2.70M 10-K · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |